Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial (COMFORT)
Primary Purpose
Hypertension
Status
Completed
Phase
Phase 3
Locations
Japan
Study Type
Interventional
Intervention
Combination pill of losartan and hydrochlorothiazide
Sponsored by

About this trial
This is an interventional treatment trial for Hypertension focused on measuring Hypertension, combination pill, compliance
Eligibility Criteria
Inclusion Criteria:
- Aged 20 years or above
- Hypertension defined as blood pressure levels of >/=140/90mmHg or current use of blood pressure lowering drugs
- Able to commence combination therapy of angiotensin receptor antagonists and diuretics
Exclusion Criteria:
- Blood pressure measurements of >/=200/120mmHg
- Previous serious adverse events due to angiotensin receptor antagonists or diuretics
- Known or possible pregnancy
- Known severe liver dysfunction
- Known severe kidney disease
- Known contraindication to angiotensin receptor antagonists or diuretics
- Taking >/=4 tablets except for angiotensin receptor antagonists
- ACE inhibitors, thiazide or thiazide-like diuretics in the morning
- Current participation in another clinical trial
- A high likelihood that the patient is not suitable for the study treatment
Sites / Locations
- Department of Medicine and Clinical Science, Kyushu University
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
No Intervention
Arm Label
Combination pill
Control group
Arm Description
Combination pill of losartan potassium 50mg and hydrochlorothiazide 12.5mg in the morning
combination therapy of angiotensin receptor antagonists (losartan potassium 50mg, candesartan 8mg, valsartan 80mg, telmisartan 40mg or olmesartan 20mg) and thiazide or thiazide-like diuretics (hydrochlorothiazide 6.25-12.5mg, trichlormethiazide 0.5-1.0mg, indapamide 0.5-1.0mg or chlorthalidone 6.25-12.5mg)
Outcomes
Primary Outcome Measures
Medication compliance
Secondary Outcome Measures
Blood pressure
cost of blood pressure lowering drugs
serious adverse events
adverse events
blood test
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00670787
Brief Title
Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial
Acronym
COMFORT
Official Title
A Randomized Trial to Establish the Effects of Combination Pill of Losartan Potassium and Hydrochlorothiazide on Medication Compliance Among Patients With High Blood Pressure.
Study Type
Interventional
2. Study Status
Record Verification Date
March 2011
Overall Recruitment Status
Completed
Study Start Date
June 2008 (undefined)
Primary Completion Date
November 2010 (Actual)
Study Completion Date
February 2011 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Kyushu University
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of the study is to determine whether combination pill of losartan potassium and hydrochlorothiazide will improve medication compliance among patients with high blood pressure.
Detailed Description
Despite clear evidence that blood pressure lowering treatment is beneficial for reduction of cardiovascular disease, blood pressure levels are not adequately controlled in many hypertensive patients. More intensive blood pressure lowering treatment is required to achieve maximum reduction of cardiovascular disease. Combination pills of blood pressure lowering drugs could be a safe and effective strategy to achieve blood pressure target but there is no randomized evidence that established the beneficial effects of combination pills of blood pressure lowering drugs. The purpose of the study is to determine whether combination pill of losartan potassium and hydrochlorothiazide will improve medication compliance among patients with high blood pressure.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
Hypertension, combination pill, compliance
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
207 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Combination pill
Arm Type
Active Comparator
Arm Description
Combination pill of losartan potassium 50mg and hydrochlorothiazide 12.5mg in the morning
Arm Title
Control group
Arm Type
No Intervention
Arm Description
combination therapy of angiotensin receptor antagonists (losartan potassium 50mg, candesartan 8mg, valsartan 80mg, telmisartan 40mg or olmesartan 20mg) and thiazide or thiazide-like diuretics (hydrochlorothiazide 6.25-12.5mg, trichlormethiazide 0.5-1.0mg, indapamide 0.5-1.0mg or chlorthalidone 6.25-12.5mg)
Intervention Type
Drug
Intervention Name(s)
Combination pill of losartan and hydrochlorothiazide
Other Intervention Name(s)
Preminent
Intervention Description
Combination pill of losartan potassium 50mg and hydrochlorothiazide 12.5mg in the morning
Primary Outcome Measure Information:
Title
Medication compliance
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Blood pressure
Time Frame
6 months
Title
cost of blood pressure lowering drugs
Time Frame
6 months
Title
serious adverse events
Time Frame
6 months
Title
adverse events
Time Frame
6 months
Title
blood test
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Aged 20 years or above
Hypertension defined as blood pressure levels of >/=140/90mmHg or current use of blood pressure lowering drugs
Able to commence combination therapy of angiotensin receptor antagonists and diuretics
Exclusion Criteria:
Blood pressure measurements of >/=200/120mmHg
Previous serious adverse events due to angiotensin receptor antagonists or diuretics
Known or possible pregnancy
Known severe liver dysfunction
Known severe kidney disease
Known contraindication to angiotensin receptor antagonists or diuretics
Taking >/=4 tablets except for angiotensin receptor antagonists
ACE inhibitors, thiazide or thiazide-like diuretics in the morning
Current participation in another clinical trial
A high likelihood that the patient is not suitable for the study treatment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kiyoshi Matsumura, MD PhD
Organizational Affiliation
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Medicine and Clinical Science, Kyushu University
City
Fukuoka City
State/Province
Fukuoka
ZIP/Postal Code
812-8582
Country
Japan
12. IPD Sharing Statement
Learn more about this trial
Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial
We'll reach out to this number within 24 hrs